Zkusit zdarma
Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

CLDX
Cena:
$ 30.73
+0.15 (0.49%)
Valuace
70
Růst
23
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

18:55 07-05-2026

Celldex Therapeutics (CLDX) came out with a quarterly loss of $1.18 per share versus the Zacks Conse...

Celldex Reports First Quarter Financial Results and Provides Corporate Update

Celldex Reports First Quarter Financial Results and Provides Corporate Update

16:01 07-05-2026

HAMPTON, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today reported financial resul...

Wall Street Analysts See a 76.42% Upside in Celldex (CLDX): Can the Stock Really Move This High?

Wall Street Analysts See a 76.42% Upside in Celldex (CLDX): Can the Stock Really Move This High?

10:56 04-05-2026

The mean of analysts' price targets for Celldex (CLDX) points to a 76.4% upside in the stock. While ...

Celldex Therapeutics Spotlights Barzolvolimab as Phase III CSU Data Looms After Fast Enrollment

Celldex Therapeutics Spotlights Barzolvolimab as Phase III CSU Data Looms After Fast Enrollment

3:35 15-04-2026

Celldex Therapeutics (NASDAQ: CLDX) executives used an appearance at H.C. Wainwright's annual Inflam...

Celldex to Present at Upcoming Investor Conference

Celldex to Present at Upcoming Investor Conference

16:01 13-04-2026

HAMPTON, N.J., April 13, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that managem...

SG Americas Securities LLC Has $1.29 Million Holdings in Celldex Therapeutics, Inc. $CLDX

SG Americas Securities LLC Has $1.29 Million Holdings in Celldex Therapeutics, Inc. $CLDX

4:46 08-04-2026

SG Americas Securities LLC grew its position in Celldex Therapeutics, Inc. (NASDAQ: CLDX) by 143.2% ...

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Celldex Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

10:53 06-04-2026

HAMPTON, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the ...

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

Celldex Announces Pricing of $300 Million Public Offering of Common Stock

21:48 01-04-2026

HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the ...

Celldex Announces Proposed Public Offering of Common Stock

Celldex Announces Proposed Public Offering of Common Stock

16:01 01-04-2026

HAMPTON, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the ...

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

10:30 27-03-2026

- Improvements seen across all six DLQI Domains indicating broad, beneficial impact on quality of li...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

2:22 23-03-2026

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report) has earned an average recommendation of ...

Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile

Celldex Announces Multiple Upcoming Presentations at AAAAI 2026 Supporting Barzolvolimab's First-in-Class and Best-in-Disease Profile

8:01 23-02-2026

HAMPTON, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that multiple...

Celldex to Present at Upcoming Investor Conferences

Celldex to Present at Upcoming Investor Conferences

8:01 09-02-2026

HAMPTON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that manageme...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Interest Update

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Short Interest Update

4:53 21-01-2026

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report) was the recipient of a significant growt...

Celldex Therapeutics SVPs Engage In Heavy Transactions

Celldex Therapeutics SVPs Engage In Heavy Transactions

10:34 12-01-2026

Multiple Senior Vice Presidents of this biotech company recently engaged in transactions that involv...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of “Moderate Buy” by Analysts

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of “Moderate Buy” by Analysts

1:30 07-01-2026

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report) has been assigned a consensus recommenda...

Celldex Therapeutics (NASDAQ:CLDX) Trading Up 4.1% – What’s Next?

Celldex Therapeutics (NASDAQ:CLDX) Trading Up 4.1% – What’s Next?

3:38 02-01-2026

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report)'s share price shot up 4.1% during mid-da...

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

Celldex Therapeutics (NASDAQ:CLDX) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened

3:17 30-12-2025

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report) shares passed above its two hundred day ...

Corient Private Wealth LLC Purchases Shares of 201,717 Celldex Therapeutics, Inc. $CLDX

Corient Private Wealth LLC Purchases Shares of 201,717 Celldex Therapeutics, Inc. $CLDX

3:34 21-12-2025

Corient Private Wealth LLC acquired a new position in shares of Celldex Therapeutics, Inc. (NASDAQ: ...

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of “Moderate Buy” from Brokerages

Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Average Recommendation of “Moderate Buy” from Brokerages

1:16 13-12-2025

Celldex Therapeutics, Inc. (NASDAQ: CLDX - Get Free Report) has received a consensus rating of "Mode...

close

CELLDEX TO PRESENT AT UPCOMING INVESTOR CONFERENCES

09-02-2026
HAMPTON, N.J., FEB. 09, 2026 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ:CLDX) ANNOUNCED TODAY THAT MANAGEME...
Více zde

CELLDEX INITIATES GLOBAL REGISTRATIONAL PHASE 3 PROGRAM OF BARZOLVOLIMAB IN COLD URTICARIA AND SYMPTOMATIC DERMOGRAPHISM

09-12-2025
HAMPTON, N.J., DEC. 09, 2025 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ:CLDX) ANNOUNCED TODAY THE INITIATIO...
Více zde

CELLDEX ANNOUNCES APPOINTMENT OF TERI LAWVER AS CHIEF COMMERCIAL OFFICER

10-11-2025
HAMPTON, N.J., NOV. 10, 2025 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ: CLDX) TODAY ANNOUNCED THE APPOINTM...
Více zde

CELLDEX TO PRESENT AT UPCOMING INVESTOR CONFERENCES

07-11-2025
HAMPTON, N.J., NOV. 07, 2025 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ:CLDX) ANNOUNCED TODAY THAT MANAGEME...
Více zde

CELLDEX PRESENTS DATA DEMONSTRATING BARZOLVOLIMAB IMPROVES CHRONIC SPONTANEOUS URTICARIA INDEPENDENT OF BASELINE IMMUNOGLOBULIN E LEVELS IN PHASE 2 STUDY AT EADV CONGRESS 2025

17-09-2025
RAPID AND SUSTAINED EFFICACY REGARDLESS OF BASELINE IGE LEVELS IN PATIENTS WITH CSU RAPID AND SUSTAI...
Více zde

CELLDEX TO PRESENT AT MORGAN STANLEY 23RD ANNUAL GLOBAL HEALTHCARE CONFERENCE

09-09-2025
HAMPTON, N.J., SEPT. 09, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCE...
Více zde

CELLDEX REPORTS RESULTS FROM PHASE 2 STUDY OF BARZOLVOLIMAB IN EOSINOPHILIC ESOPHAGITIS (EOE)

19-08-2025
HAMPTON, N.J., AUG. 19, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPO...
Více zde

CELLDEX REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

07-08-2025
HAMPTON, N.J., AUG. 07, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPO...
Více zde

CELLDEX PRESENTS DATA DEMONSTRATING PROFOUND LONG TERM IMPROVEMENT IN ANGIOEDEMA IN BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC SPONTANEOUS URTICARIA AT EAACI 2025

14-06-2025
HAMPTON, N.J., JUNE 14, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY ANNO...
Více zde

CELLDEX PRESENTS UNPRECEDENTED 76 WEEK RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC SPONTANEOUS URTICARIA AT EAACI CONGRESS 2025

12-06-2025
HAMPTON, N.J., JUNE 12, 2025 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ:CLDX) ANNOUNCED TODAY NEW DATA DEMO...
Více zde

CELLDEX ANNOUNCES UPCOMING PRESENTATIONS OF BARZOLVOLIMAB PHASE 2 DATA IN CHRONIC SPONTANEOUS URTICARIA AT EAACI 2025 CONGRESS

10-06-2025
HAMPTON, N.J., JUNE 10, 2025 (GLOBE NEWSWIRE) -- CELLDEX (NASDAQ:CLDX) ANNOUNCED TODAY THAT DATA FRO...
Více zde

CELLDEX THERAPEUTICS ANNOUNCES ELECTION OF DENICE TORRES TO ITS BOARD OF DIRECTORS

06-06-2025
HAMPTON, N.J., JUNE 06, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY ANNO...
Více zde

CELLDEX REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08-05-2025
HAMPTON, N.J., MAY 08, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPOR...
Více zde

CELLDEX PRESENTS HISTOLOGY DATA FROM PHASE 2 STUDY OF BARZOLVOLIMAB IN EOE SUPPORTING POTENTIAL OF MAST DEPLETING AGENT IN THIS DIFFICULT TO TREAT DISEASE

05-05-2025
HAMPTON, N.J., MAY 05, 2025 (GLOBE NEWSWIRE) -- CELLDEX ANNOUNCED TODAY THE PRESENTATION OF HISTOLOG...
Více zde

CELLDEX THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

04-03-2025
HAMPTON, N.J., MARCH 04, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED...
Více zde

CELLDEX THERAPEUTICS PRESENTS POSITIVE PRECLINICAL DATA FROM INFLAMMATORY BISPECIFIC ANTIBODY PROGRAM CDX-622 AT AAAAI 2025

03-03-2025
- CDX-622 INHIBITS SCF AND TSLP-DEPENDENT INFLAMMATORY SIGNATURES IN HUMAN SKIN - - PHASE 1 STUDY IN...
Více zde

CELLDEX THERAPEUTICS PRESENTS POSITIVE RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDIES IN PATIENTS WITH CHRONIC URTICARIA DEMONSTRATING IMPROVED DISEASE CONTROL AND QUALITY OF LIFE AT AAAAI 2025

01-03-2025
- GREATLY IMPROVED PATIENT QUALITY OF LIFE AND REDUCED DISEASE IMPACT IN PATIENTS WITH CSU AND CINDU...
Více zde

CELLDEX REPORTS FOURTH QUARTER AND YEAR END 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

27-02-2025
HAMPTON, N.J., FEB. 27, 2025 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPO...
Více zde

CELLDEX INITIATES PHASE 2 STUDY OF BARZOLVOLIMAB IN ATOPIC DERMATITIS

19-12-2024
HAMPTON, N.J., DEC. 19, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY ANNO...
Více zde

CELLDEX ANNOUNCES FIRST PATIENT DOSED IN PHASE 1 HEALTHY VOLUNTEER STUDY OF CDX-622, A BISPECIFIC ANTIBODY, FOR THE TREATMENT OF INFLAMMATORY DISEASES

20-11-2024
HAMPTON, N.J., NOV. 20, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY ANNO...
Více zde

CELLDEX THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

11-11-2024
HAMPTON, N.J., NOV. 11, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED ...
Více zde

CELLDEX REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

06-11-2024
HAMPTON, N.J., NOV. 06, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPO...
Více zde

CELLDEX ANNOUNCES BARZOLVOLIMAB MET ALL PRIMARY AND SECONDARY ENDPOINTS WITH HIGH STATISTICAL SIGNIFICANCE IN POSITIVE PHASE 2 STUDY IN CHRONIC INDUCIBLE URTICARIA

26-10-2024
HAMPTON, N.J., OCT. 26, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED ...
Více zde

CELLDEX ANNOUNCES UPCOMING LATE BREAKING ORAL PRESENTATION OF 12 WEEK RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC INDUCIBLE URTICARIA AT ACAAI 2024

25-10-2024
HAMPTON, N.J., OCT. 25, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED ...
Více zde

CELLDEX THERAPEUTICS PRESENTS LANDMARK 52 WEEK RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC SPONTANEOUS URTICARIA AT EADV 2024

25-09-2024
- 71% OF PATIENTS (150 MG Q4W) ACHIEVED COMPLETE RESPONSE AT WEEK 52 - - RAPID, PROFOUND AND DURABLE...
Více zde

CELLDEX ANNOUNCES UPCOMING LATE BREAKING ORAL PRESENTATION OF 52 WEEK RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC SPONTANEOUS URTICARIA AT EADV CONGRESS 2024

16-09-2024
HAMPTON, N.J., SEPT. 16, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED...
Více zde

CELLDEX THERAPEUTICS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

12-09-2024
HAMPTON, N.J., SEPT. 12, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED...
Více zde

CELLDEX REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

08-08-2024
HAMPTON, N.J., AUG. 08, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) TODAY REPO...
Více zde

CELLDEX THERAPEUTICS PRESENTS POSITIVE TOPLINE RESULTS FROM BARZOLVOLIMAB PHASE 2 STUDY IN CHRONIC INDUCIBLE URTICARIA

29-07-2024
HAMPTON, N.J., JULY 29, 2024 (GLOBE NEWSWIRE) -- CELLDEX THERAPEUTICS, INC. (NASDAQ:CLDX) ANNOUNCED ...
Více zde

CELLDEX THERAPEUTICS INITIATES GLOBAL PHASE 3 PROGRAM FOR BARZOLVOLIMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA

16-07-2024
- EMBARQ-CSU1 AND EMBARQ-CSU 2 WILL ENROLL MORE THAN 1800 PATIENTS SUFFERING FROM CSU - - STUDIES IN...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-08-19 01:00:008-KStáhnout
2025-08-19 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-06 01:00:008-KStáhnout
2025-06-06 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2024-11-06 00:00:008-KStáhnout
2024-11-06 00:00:0010-QStáhnout
2024-11-05 23:00:008-KStáhnout
2024-11-05 23:00:0010-QStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-05-06 01:00:008-KStáhnout
2024-05-06 01:00:0010-QStáhnout
2024-05-06 00:00:008-KStáhnout
2024-05-06 00:00:0010-QStáhnout
2024-03-01 00:00:008-KStáhnout
2024-02-29 23:00:008-KStáhnout
2024-02-26 00:00:008-KStáhnout
2024-02-26 00:00:0010-KStáhnout
2024-02-25 23:00:008-KStáhnout
2024-02-25 23:00:0010-KStáhnout
2023-11-08 00:00:008-KStáhnout
2023-11-07 23:00:008-KStáhnout
2023-11-06 00:00:008-KStáhnout
2023-11-05 23:00:008-KStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:008-KStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-08-08 01:00:008-KStáhnout
2023-08-08 01:00:0010-QStáhnout
2023-08-08 00:00:008-KStáhnout
2023-08-08 00:00:0010-QStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-05-04 01:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:008-KStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-03-22 00:00:008-KStáhnout
2023-03-21 23:00:008-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-28 00:00:0010-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-02-27 23:00:0010-KStáhnout
2023-02-21 00:00:008-KStáhnout
2023-02-20 23:00:008-KStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-09 00:00:0010-QStáhnout
2022-11-08 23:00:008-KStáhnout
2022-11-08 23:00:0010-QStáhnout
2022-08-08 01:00:008-KStáhnout
2022-08-08 01:00:0010-QStáhnout
2022-08-08 00:00:008-KStáhnout
2022-08-08 00:00:0010-QStáhnout
2022-07-18 01:00:008-KStáhnout
2022-07-18 00:00:008-KStáhnout
2022-06-23 01:00:008-KStáhnout
2022-06-23 00:00:008-KStáhnout
2022-06-16 01:00:008-KStáhnout
2022-06-16 00:00:008-KStáhnout
2022-05-05 01:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:008-KStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-02-28 00:00:008-KStáhnout
2022-02-28 00:00:0010-KStáhnout
2022-02-27 23:00:008-KStáhnout
2022-02-27 23:00:0010-KStáhnout
2022-01-28 00:00:008-KStáhnout
2022-01-27 23:00:008-KStáhnout
2021-11-09 00:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:008-KStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-08-05 01:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:008-KStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-07-14 01:00:008-KStáhnout
2021-07-14 00:00:008-KStáhnout
2021-07-12 01:00:008-KStáhnout
2021-07-12 00:00:008-KStáhnout
2021-07-01 01:00:008-KStáhnout
2021-07-01 00:00:008-KStáhnout
2021-06-17 01:00:008-KStáhnout
2021-06-17 00:00:008-KStáhnout
2021-05-06 01:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:008-KStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-03-29 01:00:008-KStáhnout
2021-03-29 01:00:0010-KStáhnout
2021-03-29 00:00:008-KStáhnout
2021-03-29 00:00:0010-KStáhnout
2021-01-04 00:00:008-KStáhnout
2021-01-03 23:00:008-KStáhnout
2020-11-06 00:00:008-KStáhnout
2020-11-05 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-08-18 01:00:008-KStáhnout
2020-08-18 00:00:008-KStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 01:00:0010-QStáhnout
2020-08-06 00:00:008-KStáhnout
2020-08-06 00:00:0010-QStáhnout
2020-06-18 01:00:008-KStáhnout
2020-06-18 00:00:008-KStáhnout
2020-06-17 01:00:008-KStáhnout
2020-06-17 00:00:008-KStáhnout
2020-06-15 01:00:008-KStáhnout
2020-06-15 00:00:008-KStáhnout
2020-06-12 01:00:008-KStáhnout
2020-06-12 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 01:00:0010-QStáhnout
2020-05-06 00:00:008-KStáhnout
2020-05-06 00:00:0010-QStáhnout
2020-03-26 00:00:008-KStáhnout
2020-03-26 00:00:0010-KStáhnout
2020-03-25 23:00:008-KStáhnout
2020-03-25 23:00:0010-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-08-07 01:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:008-KStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-06-24 01:00:008-KStáhnout
2019-06-24 00:00:008-KStáhnout
2019-06-20 01:00:008-KStáhnout
2019-06-20 00:00:008-KStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:008-KStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-03-07 00:00:008-KStáhnout
2019-03-07 00:00:0010-KStáhnout
2019-03-06 23:00:008-KStáhnout
2019-03-06 23:00:0010-KStáhnout
2019-02-08 00:00:008-KStáhnout
2019-02-07 23:00:008-KStáhnout
2018-12-10 00:00:008-KStáhnout
2018-12-09 23:00:008-KStáhnout
2018-11-27 00:00:008-KStáhnout
2018-11-26 23:00:008-KStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-07 00:00:0010-QStáhnout
2018-11-06 23:00:008-KStáhnout
2018-11-06 23:00:0010-QStáhnout
2018-08-08 01:00:008-KStáhnout
2018-08-08 01:00:0010-QStáhnout
2018-08-08 00:00:008-KStáhnout
2018-08-08 00:00:0010-QStáhnout
2018-06-14 01:00:008-KStáhnout
2018-06-14 00:00:008-KStáhnout
2018-06-01 01:00:008-KStáhnout
2018-06-01 00:00:008-KStáhnout
2018-05-10 01:00:008-KStáhnout
2018-05-10 01:00:0010-QStáhnout
2018-05-10 00:00:008-KStáhnout
2018-05-10 00:00:0010-QStáhnout
2018-04-24 01:00:008-KStáhnout
2018-04-24 00:00:008-KStáhnout
2018-04-16 01:00:008-KStáhnout
2018-04-16 00:00:008-KStáhnout
2018-03-07 00:00:008-KStáhnout
2018-03-07 00:00:0010-KStáhnout
2018-03-06 23:00:008-KStáhnout
2018-03-06 23:00:0010-KStáhnout
2017-12-29 00:00:008-KStáhnout
2017-12-28 23:00:008-KStáhnout
2017-11-09 00:00:008-KStáhnout
2017-11-08 23:00:008-KStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-07 00:00:0010-QStáhnout
2017-11-06 23:00:008-KStáhnout
2017-11-06 23:00:0010-QStáhnout
2017-10-03 01:00:008-KStáhnout
2017-10-03 00:00:008-KStáhnout
2017-09-12 01:00:008-KStáhnout
2017-09-12 00:00:008-KStáhnout
2017-08-08 01:00:008-KStáhnout
2017-08-08 01:00:0010-QStáhnout
2017-08-08 00:00:008-KStáhnout
2017-08-08 00:00:0010-QStáhnout
2017-07-05 01:00:008-KStáhnout
2017-07-05 00:00:008-KStáhnout
2017-06-16 01:00:008-KStáhnout
2017-06-16 00:00:008-KStáhnout
2017-05-09 01:00:008-KStáhnout
2017-05-09 01:00:0010-QStáhnout
2017-05-09 00:00:008-KStáhnout
2017-05-09 00:00:0010-QStáhnout
2017-03-14 00:00:008-KStáhnout
2017-03-14 00:00:0010-KStáhnout
2017-03-13 23:00:008-KStáhnout
2017-03-13 23:00:0010-KStáhnout
2017-03-01 00:00:008-KStáhnout
2017-02-28 23:00:008-KStáhnout
2016-12-14 00:00:008-KStáhnout
2016-12-13 23:00:008-KStáhnout
2016-12-05 00:00:008-KStáhnout
2016-12-04 23:00:008-KStáhnout
2016-11-29 00:00:008-KStáhnout
2016-11-28 23:00:008-KStáhnout
2016-11-07 00:00:008-KStáhnout
2016-11-07 00:00:0010-QStáhnout
2016-11-06 23:00:008-KStáhnout
2016-11-06 23:00:0010-QStáhnout
2016-11-01 00:00:008-KStáhnout
2016-10-31 23:00:008-KStáhnout
2016-08-11 01:00:008-KStáhnout
2016-08-11 00:00:008-KStáhnout
2016-08-08 01:00:008-KStáhnout
2016-08-08 01:00:0010-QStáhnout
2016-08-08 00:00:008-KStáhnout
2016-08-08 00:00:0010-QStáhnout
2016-06-09 01:00:008-KStáhnout
2016-06-09 00:00:008-KStáhnout
2016-05-19 01:00:008-KStáhnout
2016-05-19 00:00:008-KStáhnout
2016-05-05 01:00:008-KStáhnout
2016-05-05 01:00:0010-QStáhnout
2016-05-05 00:00:008-KStáhnout
2016-05-05 00:00:0010-QStáhnout
2016-03-07 00:00:008-KStáhnout
2016-03-06 23:00:008-KStáhnout
2016-02-25 00:00:008-KStáhnout
2016-02-24 23:00:008-KStáhnout
2016-02-23 00:00:008-KStáhnout
2016-02-23 00:00:0010-KStáhnout
2016-02-22 23:00:008-KStáhnout
2016-02-22 23:00:0010-KStáhnout
2015-11-05 00:00:008-KStáhnout
2015-11-05 00:00:0010-QStáhnout
2015-11-04 23:00:008-KStáhnout
2015-11-04 23:00:0010-QStáhnout
2015-08-10 01:00:008-KStáhnout
2015-08-10 01:00:0010-QStáhnout
2015-08-10 00:00:008-KStáhnout
2015-08-10 00:00:0010-QStáhnout
2015-06-11 01:00:008-KStáhnout
2015-06-11 00:00:008-KStáhnout
2015-04-29 01:00:008-KStáhnout
2015-04-29 01:00:0010-QStáhnout
2015-04-29 00:00:008-KStáhnout
2015-04-29 00:00:0010-QStáhnout
2015-02-26 00:00:008-KStáhnout
2015-02-25 23:00:008-KStáhnout
2015-02-24 00:00:008-KStáhnout
2015-02-24 00:00:0010-KStáhnout
2015-02-23 23:00:008-KStáhnout
2015-02-23 23:00:0010-KStáhnout
2014-12-18 00:00:008-KStáhnout
2014-12-17 23:00:008-KStáhnout
2014-11-06 00:00:008-KStáhnout
2014-11-05 23:00:008-KStáhnout
2014-11-05 00:00:0010-QStáhnout
2014-11-04 23:00:0010-QStáhnout
2014-11-04 00:00:008-KStáhnout
2014-11-03 23:00:008-KStáhnout
2014-10-20 01:00:008-KStáhnout
2014-10-20 00:00:008-KStáhnout
2014-08-07 01:00:0010-QStáhnout
2014-08-07 00:00:0010-QStáhnout
2014-08-06 01:00:008-KStáhnout
2014-08-06 00:00:008-KStáhnout
2014-05-29 01:00:008-KStáhnout
2014-05-29 00:00:008-KStáhnout
2014-05-14 01:00:008-KStáhnout
2014-05-14 00:00:008-KStáhnout
2014-05-01 01:00:008-KStáhnout
2014-05-01 01:00:0010-QStáhnout
2014-05-01 00:00:008-KStáhnout
2014-05-01 00:00:0010-QStáhnout
2014-04-08 01:00:008-KStáhnout
2014-04-08 00:00:008-KStáhnout
2014-03-03 00:00:008-KStáhnout
2014-03-03 00:00:0010-KStáhnout
2014-03-02 23:00:008-KStáhnout
2014-03-02 23:00:0010-KStáhnout
2013-12-05 00:00:008-KStáhnout
2013-12-04 23:00:008-KStáhnout
2013-11-25 00:00:008-KStáhnout
2013-11-24 23:00:008-KStáhnout
2013-11-08 00:00:008-KStáhnout
2013-11-08 00:00:0010-QStáhnout
2013-11-07 23:00:008-KStáhnout
2013-11-07 23:00:0010-QStáhnout
2013-08-06 01:00:0010-QStáhnout
2013-08-06 00:00:0010-QStáhnout
2013-06-13 01:00:008-KStáhnout
2013-06-13 00:00:008-KStáhnout
2013-05-20 01:00:008-KStáhnout
2013-05-20 00:00:008-KStáhnout
2013-05-03 01:00:0010-QStáhnout
2013-05-03 00:00:0010-QStáhnout
2013-05-02 01:00:008-KStáhnout
2013-05-02 00:00:008-KStáhnout
2013-03-08 00:00:0010-KStáhnout
2013-03-07 23:00:0010-KStáhnout
2013-03-07 00:00:008-KStáhnout
2013-03-06 23:00:008-KStáhnout
2013-02-06 00:00:008-KStáhnout
2013-02-05 23:00:008-KStáhnout
2013-02-04 00:00:008-KStáhnout
2013-02-03 23:00:008-KStáhnout
2013-01-07 00:00:008-KStáhnout
2013-01-06 23:00:008-KStáhnout
2012-12-21 00:00:008-KStáhnout
2012-12-20 23:00:008-KStáhnout
2012-11-02 00:00:0010-QStáhnout
2012-11-01 23:00:0010-QStáhnout
2012-11-01 00:00:008-KStáhnout
2012-10-31 23:00:008-KStáhnout
2012-09-24 01:00:008-KStáhnout
2012-09-24 00:00:008-KStáhnout
2012-08-10 01:00:008-KStáhnout
2012-08-10 00:00:008-KStáhnout
2012-08-09 01:00:0010-QStáhnout
2012-08-09 00:00:0010-QStáhnout
2012-06-14 01:00:008-KStáhnout
2012-06-14 00:00:008-KStáhnout
2012-05-24 01:00:008-KStáhnout
2012-05-24 00:00:008-KStáhnout
2012-05-04 01:00:0010-QStáhnout
2012-05-04 00:00:0010-QStáhnout
2012-05-03 01:00:008-KStáhnout
2012-05-03 00:00:008-KStáhnout
2012-04-03 01:00:008-KStáhnout
2012-04-03 00:00:008-KStáhnout
2012-03-08 00:00:0010-KStáhnout
2012-03-07 23:00:0010-KStáhnout
2012-03-07 00:00:008-KStáhnout
2012-03-06 23:00:008-KStáhnout
2012-02-24 00:00:008-KStáhnout
2012-02-23 23:00:008-KStáhnout
2012-02-23 00:00:008-KStáhnout
2012-02-22 23:00:008-KStáhnout
2011-11-03 00:00:0010-QStáhnout
2011-11-02 23:00:0010-QStáhnout
2011-11-02 00:00:008-KStáhnout
2011-11-01 23:00:008-KStáhnout
2011-08-04 01:00:0010-QStáhnout
2011-08-04 00:00:0010-QStáhnout
2011-08-03 01:00:008-KStáhnout
2011-08-03 00:00:008-KStáhnout
2011-07-06 01:00:008-KStáhnout
2011-07-06 00:00:008-KStáhnout
2011-06-16 01:00:008-KStáhnout
2011-06-16 00:00:008-KStáhnout
2011-05-18 01:00:008-KStáhnout
2011-05-18 00:00:008-KStáhnout
2011-05-05 01:00:0010-QStáhnout
2011-05-05 00:00:0010-QStáhnout
2011-05-04 01:00:008-KStáhnout
2011-05-04 00:00:008-KStáhnout
2011-03-09 00:00:0010-KStáhnout
2011-03-08 23:00:0010-KStáhnout
2011-03-03 00:00:008-KStáhnout
2011-03-02 23:00:008-KStáhnout
2011-01-06 00:00:008-KStáhnout
2011-01-05 23:00:008-KStáhnout
2010-11-04 00:00:0010-QStáhnout
2010-11-03 23:00:0010-QStáhnout
2010-11-02 00:00:008-KStáhnout
2010-11-01 23:00:008-KStáhnout
2010-09-16 01:00:008-KStáhnout
2010-09-16 00:00:008-KStáhnout
2010-09-07 01:00:008-KStáhnout
2010-09-07 00:00:008-KStáhnout
2010-08-05 01:00:0010-QStáhnout
2010-08-05 00:00:0010-QStáhnout
2010-08-04 01:00:008-KStáhnout
2010-08-04 00:00:008-KStáhnout
2010-05-06 01:00:0010-QStáhnout
2010-05-06 00:00:0010-QStáhnout
2010-05-04 01:00:008-KStáhnout
2010-05-04 00:00:008-KStáhnout
2010-03-30 01:00:008-KStáhnout
2010-03-30 00:00:008-KStáhnout
2010-03-12 00:00:0010-KStáhnout
2010-03-11 23:00:0010-KStáhnout
2010-03-04 00:00:008-KStáhnout
2010-03-03 23:00:008-KStáhnout
2010-02-16 00:00:008-KStáhnout
2010-02-15 23:00:008-KStáhnout
2010-01-25 00:00:008-KStáhnout
2010-01-24 23:00:008-KStáhnout
2010-01-08 00:00:008-KStáhnout
2010-01-07 23:00:008-KStáhnout
2009-12-31 00:00:008-KStáhnout
2009-12-30 23:00:008-KStáhnout
2009-11-06 00:00:0010-QStáhnout
2009-11-05 23:00:0010-QStáhnout
2009-11-04 00:00:008-KStáhnout
2009-11-03 23:00:008-KStáhnout
2009-10-02 01:00:008-KStáhnout
2009-10-02 00:00:008-KStáhnout
2009-09-04 01:00:008-KStáhnout
2009-09-04 00:00:008-KStáhnout
2009-08-07 01:00:0010-QStáhnout
2009-08-07 00:00:0010-QStáhnout
2009-08-05 01:00:008-KStáhnout
2009-08-05 00:00:008-KStáhnout
2009-06-02 01:00:008-KStáhnout
2009-06-02 00:00:008-KStáhnout
2009-05-29 01:00:008-KStáhnout
2009-05-29 00:00:008-KStáhnout
2009-05-08 01:00:0010-QStáhnout
2009-05-08 00:00:0010-QStáhnout
2009-05-05 01:00:008-KStáhnout
2009-05-05 00:00:008-KStáhnout
2009-03-02 00:00:0010-KStáhnout
2009-03-01 23:00:0010-KStáhnout
2009-02-27 00:00:008-KStáhnout
2009-02-26 23:00:008-KStáhnout
2009-02-05 00:00:008-KStáhnout
2009-02-04 23:00:008-KStáhnout
2009-01-08 00:00:008-KStáhnout
2009-01-07 23:00:008-KStáhnout
2008-12-08 00:00:008-KStáhnout
2008-12-07 23:00:008-KStáhnout
2008-11-10 00:00:0010-QStáhnout
2008-11-09 23:00:0010-QStáhnout
2008-11-05 00:00:008-KStáhnout
2008-11-04 23:00:008-KStáhnout
2008-09-29 01:00:008-KStáhnout
2008-09-29 00:00:008-KStáhnout
2008-08-11 01:00:0010-QStáhnout
2008-08-11 00:00:0010-QStáhnout
2008-08-06 01:00:008-KStáhnout
2008-08-06 00:00:008-KStáhnout
2008-07-28 01:00:008-KStáhnout
2008-07-28 00:00:008-KStáhnout
2008-07-18 01:00:008-KStáhnout
2008-07-18 00:00:008-KStáhnout
2008-06-09 01:00:008-KStáhnout
2008-06-09 00:00:008-KStáhnout
2008-06-02 01:00:008-KStáhnout
2008-06-02 00:00:008-KStáhnout
2008-05-30 01:00:008-KStáhnout
2008-05-30 00:00:008-KStáhnout
2008-05-19 01:00:0010-QStáhnout
2008-05-19 00:00:0010-QStáhnout
2008-05-14 01:00:008-KStáhnout
2008-05-14 00:00:008-KStáhnout
2008-04-17 01:00:008-KStáhnout
2008-04-17 00:00:008-KStáhnout
2008-03-18 00:00:0010-KStáhnout
2008-03-17 23:00:0010-KStáhnout
2008-03-11 00:00:008-KStáhnout
2008-03-10 23:00:008-KStáhnout
2008-02-27 00:00:008-KStáhnout
2008-02-26 23:00:008-KStáhnout
2008-02-12 00:00:008-KStáhnout
2008-02-11 23:00:008-KStáhnout
2008-01-16 00:00:008-KStáhnout
2008-01-15 23:00:008-KStáhnout
2008-01-09 00:00:008-KStáhnout
2008-01-08 23:00:008-KStáhnout
2007-11-27 00:00:008-KStáhnout
2007-11-26 23:00:008-KStáhnout
2007-11-07 00:00:0010-QStáhnout
2007-11-06 23:00:0010-QStáhnout
2007-11-02 00:00:008-KStáhnout
2007-11-01 23:00:008-KStáhnout
2007-10-31 00:00:008-KStáhnout
2007-10-30 23:00:008-KStáhnout
2007-10-23 01:00:008-KStáhnout
2007-10-23 00:00:008-KStáhnout
2007-10-17 01:00:008-KStáhnout
2007-10-17 00:00:008-KStáhnout
2007-08-30 01:00:008-KStáhnout
2007-08-30 00:00:008-KStáhnout
2007-08-21 01:00:008-KStáhnout
2007-08-21 00:00:008-KStáhnout
2007-08-09 01:00:008-KStáhnout
2007-08-09 00:00:008-KStáhnout
2007-08-08 01:00:0010-QStáhnout
2007-08-08 00:00:0010-QStáhnout
2007-08-02 01:00:008-KStáhnout
2007-08-02 00:00:008-KStáhnout
2007-07-10 01:00:008-KStáhnout
2007-07-10 00:00:008-KStáhnout
2007-07-02 01:00:008-KStáhnout
2007-07-02 00:00:008-KStáhnout
2007-05-09 01:00:0010-QStáhnout
2007-05-09 00:00:0010-QStáhnout
2007-05-03 01:00:008-KStáhnout
2007-05-03 00:00:008-KStáhnout
2007-04-17 01:00:008-KStáhnout
2007-04-17 00:00:008-KStáhnout
2007-04-16 01:00:008-KStáhnout
2007-04-16 00:00:008-KStáhnout
2007-03-16 00:00:0010-KStáhnout
2007-03-15 23:00:0010-KStáhnout
2007-03-07 00:00:008-KStáhnout
2007-03-06 23:00:008-KStáhnout
2006-11-09 00:00:0010-QStáhnout
2006-11-08 23:00:0010-QStáhnout
2006-11-01 00:00:008-KStáhnout
2006-10-31 23:00:008-KStáhnout
2006-09-21 01:00:008-KStáhnout
2006-09-21 00:00:008-KStáhnout
2006-08-09 01:00:0010-QStáhnout
2006-08-09 00:00:0010-QStáhnout
2006-08-02 01:00:008-KStáhnout
2006-08-02 00:00:008-KStáhnout
2006-05-10 01:00:0010-QStáhnout
2006-05-10 00:00:0010-QStáhnout
2006-05-09 01:00:008-KStáhnout
2006-05-09 00:00:008-KStáhnout
2006-03-16 00:00:0010-KStáhnout
2006-03-15 23:00:0010-KStáhnout
2006-03-15 00:00:008-KStáhnout
2006-03-14 23:00:008-KStáhnout
2006-03-08 00:00:008-KStáhnout
2006-03-07 23:00:008-KStáhnout
2005-11-21 00:00:008-KStáhnout
2005-11-20 23:00:008-KStáhnout
2005-11-03 00:00:0010-QStáhnout
2005-11-02 23:00:0010-QStáhnout
2005-10-27 01:00:008-KStáhnout
2005-10-27 00:00:008-KStáhnout
2005-08-09 01:00:0010-QStáhnout
2005-08-09 00:00:0010-QStáhnout
2005-08-03 01:00:008-KStáhnout
2005-08-03 00:00:008-KStáhnout
2005-05-18 01:00:008-KStáhnout
2005-05-18 00:00:008-KStáhnout
2005-05-10 01:00:0010-QStáhnout
2005-05-10 00:00:0010-QStáhnout
2005-05-05 01:00:008-KStáhnout
2005-05-05 00:00:008-KStáhnout
2005-03-22 00:00:008-KStáhnout
2005-03-21 23:00:008-KStáhnout
2005-03-16 00:00:0010-KStáhnout
2005-03-15 23:00:0010-KStáhnout
2005-03-02 00:00:008-KStáhnout
2005-03-01 23:00:008-KStáhnout
2004-11-12 00:00:008-KStáhnout
2004-11-11 23:00:008-KStáhnout
2004-11-09 00:00:0010-QStáhnout
2004-11-08 23:00:0010-QStáhnout
2004-11-08 00:00:008-KStáhnout
2004-11-07 23:00:008-KStáhnout
2004-10-21 01:00:008-KStáhnout
2004-10-21 00:00:008-KStáhnout
2004-08-05 01:00:0010-QStáhnout
2004-08-05 00:00:0010-QStáhnout
2004-07-22 00:00:008-KStáhnout
2004-04-30 00:00:0010-QStáhnout
2004-04-21 00:00:008-KStáhnout
2004-03-14 23:00:0010-KStáhnout
2004-02-23 23:00:008-KStáhnout
2004-02-22 23:00:008-KStáhnout
preloader